Managing for Growth from Start-Up to Initial Public Offering
نام نخستين پديدآور
by Martin Grossmann.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Heidelberg
نام ناشر، پخش کننده و غيره
Physica-Verlag HD : Imprint : Physica
تاریخ نشرو بخش و غیره
2003
مشخصات ظاهری
نام خاص و کميت اثر
(xvi, 323 pages 95 illustrations)
فروست
عنوان فروست
Contributions to management science.
یادداشتهای مربوط به مندرجات
متن يادداشت
Independent Biopharmaceutical Companies and Their Specialization in Drug Discovery Technologies --; Model Structure for High-Technology Firms and Its Dynamic Behavior in Start-Up Phases --; Model Structure and Dynamic Behavior for High-Technology Firms in Transition to Growth Phases --; Economic Value Creation in Transition Phases: Access to Equity Capital --; Strategies for Growth Phases to Sustain Independence.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Research and development of novel medicines for human therapy commonly takes over a decade before significant revenues from sales are forthcoming. How can biotechnology companies be founded and grow successfully in an industry with such extended innovation processes? The book investigates this problem and distinguishes three growth phases: From incorporation and start-up through collaborative R & D with large pharmaceutical firms to value creation from R & D pipelines to Public Offerings and product marketing. In this book a dynamic simulation model for testing different decision-making strategies is developed. For each phase the author identifies decision rules that provide for successful corporate growth.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Economics.
موضوع مستند نشده
Entrepreneurship.
موضوع مستند نشده
Toxicology.
رده بندی کنگره
شماره رده
HD9999
.
B442
نشانه اثر
B963
2003
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )